Morgan Stanley’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,416
| Closed | -$396 | – | 8080 |
|
|
2023
Q3 | $396 | Hold |
4,416
| – | – | ﹤0.01% | 7333 |
|
|
2023
Q2 | $406 | Buy |
4,416
+4,150
| +1,560% | +$382 | ﹤0.01% | 7395 |
|
|
2023
Q1 | $69 | Sell |
266
-31
| -10% | -$8 | ﹤0.01% | 7595 |
|
|
2022
Q4 | $63 | Buy |
297
+31
| +12% | +$7 | ﹤0.01% | 7723 |
|
|
2022
Q3 | $0 | Hold |
266
| – | – | ﹤0.01% | 8220 |
|
|
2022
Q2 | $0 | Sell |
266
-254
| -49% | – | ﹤0.01% | 8332 |
|
|
2022
Q1 | $0 | Buy |
520
+203
| +64% | – | ﹤0.01% | 8406 |
|
|
2021
Q4 | $0 | Sell |
317
-2,499
| -89% | – | ﹤0.01% | 8462 |
|
|
2021
Q3 | $5K | Sell |
2,816
-8,567
| -75% | -$15.2K | ﹤0.01% | 7524 |
|
|
2021
Q2 | $21K | Sell |
11,383
-7,500
| -40% | -$13.8K | ﹤0.01% | 7003 |
|
|
2021
Q1 | $38K | Buy |
18,883
+8,633
| +84% | +$17.4K | ﹤0.01% | 6483 |
|
|
2020
Q4 | $22K | Buy |
10,250
+2,500
| +32% | +$5.37K | ﹤0.01% | 6416 |
|
|
2020
Q3 | $21K | Hold |
7,750
| – | – | ﹤0.01% | 6056 |
|
|
2020
Q2 | $31K | Hold |
7,750
| – | – | ﹤0.01% | 5866 |
|
|
2020
Q1 | $6K | Sell |
7,750
-100
| -1% | -$77 | ﹤0.01% | 6178 |
|
|
2019
Q4 | $10K | Hold |
7,850
| – | – | ﹤0.01% | 6271 |
|
|
2019
Q3 | $5K | Hold |
7,850
| – | – | ﹤0.01% | 6384 |
|
|
2019
Q2 | $5K | Sell |
7,850
-15
| -0.2% | -$10 | ﹤0.01% | 6337 |
|
|
2019
Q1 | $22K | Buy |
7,865
+10
| +0.1% | +$28 | ﹤0.01% | 5990 |
|
|
2018
Q4 | $16K | Hold |
7,855
| – | – | ﹤0.01% | 6072 |
|
|
2018
Q3 | $36K | Hold |
7,855
| – | – | ﹤0.01% | 5979 |
|
|
2018
Q2 | $36K | Sell |
7,855
-488
| -6% | -$2.24K | ﹤0.01% | 6001 |
|
|
2018
Q1 | $60K | Buy |
8,343
+58
| +0.7% | +$417 | ﹤0.01% | 5843 |
|
|
2017
Q4 | $59K | Sell |
8,285
-773
| -9% | -$5.51K | ﹤0.01% | 5786 |
|
|
2017
Q3 | $75K | Buy |
9,058
+226
| +3% | +$1.87K | ﹤0.01% | 5658 |
|
|
2017
Q2 | $90K | Buy |
8,832
+54
| +0.6% | +$550 | ﹤0.01% | 5676 |
|
|
2017
Q1 | $102K | Buy |
8,778
+89
| +1% | +$1.03K | ﹤0.01% | 5595 |
|
|
2016
Q4 | $111K | Buy |
8,689
+284
| +3% | +$3.63K | ﹤0.01% | 5540 |
|
|
2016
Q3 | $154K | Sell |
8,405
-273
| -3% | -$5K | ﹤0.01% | 5120 |
|
|
2016
Q2 | $92K | Sell |
8,678
-1,429
| -14% | -$15.2K | ﹤0.01% | 5277 |
|
|
2016
Q1 | $191K | Sell |
10,107
-1,678
| -14% | -$31.7K | ﹤0.01% | 5006 |
|
|
2015
Q4 | $314K | Buy |
11,785
+1,347
| +13% | +$35.9K | ﹤0.01% | 4845 |
|
|
2015
Q3 | $476K | Buy |
10,438
+1,175
| +13% | +$53.6K | ﹤0.01% | 4644 |
|
|
2015
Q2 | $298K | Sell |
9,263
-339
| -4% | -$10.9K | ﹤0.01% | 5035 |
|
|
2015
Q1 | $305K | Sell |
9,602
-2,974
| -24% | -$94.5K | ﹤0.01% | 4964 |
|
|
2014
Q4 | $475K | Sell |
12,576
-484
| -4% | -$18.3K | ﹤0.01% | 4699 |
|
|
2014
Q3 | $345K | Buy |
13,060
+1,824
| +16% | +$48.2K | ﹤0.01% | 4815 |
|
|
2014
Q2 | $333K | Buy |
11,236
+98
| +0.9% | +$2.9K | ﹤0.01% | 4880 |
|
|
2014
Q1 | $412K | Buy |
11,138
+1,587
| +17% | +$58.7K | ﹤0.01% | 4690 |
|
|
2013
Q4 | $396K | Sell |
9,551
-321
| -3% | -$13.3K | ﹤0.01% | 4618 |
|
|
2013
Q3 | $523K | Sell |
9,872
-1,725
| -15% | -$91.4K | ﹤0.01% | 4298 |
|
|
2013
Q2 | $619K | Buy |
+11,597
| New | +$619K | ﹤0.01% | 4113 |
|